Our Products
Otsuka Canada Pharmaceutical Inc. (OCPI) is an innovative, fast-growing health care company that commercializes Otsuka medicines in Canada, with a focus on commitment to neuroscience, and nephrology. OCPI is dedicated to improving patients' health and the quality of human life.
Careers
Start a new Story at Otsuka
Come and work with a team of people who aren’t afraid to challenge convention. This approach can lead to something new, something better.
We aspire to attract best-in-class people and partners. After all, having the right team makes all the difference.
We encourage our employees to dream. Then we give them the freedom to reach for those dreams.
What is your story going to be?
News
Montreal, Canada, January 24, 2024
Health Canada Approves Otsuka and Lundbeck’s REXULTI® (brexpiprazole) for the Symptomatic Management of Agitation Associated with Alzheimer’s Dementia
tsuka Pharmaceutical Canada Inc. (Otsuka) and Lundbeck Canada Inc. (Lundbeck) announce that Health Canada has issued a Notice of Compliance for REXULTI® (brexpiprazole) for use in the symptomatic management of agitation associated with Alzheimer’s dementia (AAD) in patients with aggressive behaviour, unresponsive to non-pharmacological approaches.
Read the press release
Who We Are
Otsuka Canada Pharmaceutical Inc. (OCPI) is dedicated to improving patients' health and the quality of human life.
Our Culture
The Otsuka culture and big venture approach is our everyday story and competitive advantage.
Our History
Since 1921 we have nurtured the spirit of curiosity, creativity, and perseverance in our people, to bring healthcare products to patients worldwide.
Community Support
Find out more about how OCPI supports medical education and our involvement in the community.
Location
OCPI has it's headquarters in Technoparc Montreal, in St-Laurent, Quebec.